Company news
Crescita Therapeutics, Inc. news in 2018
Crescita Therapeutics, Inc.'s news releases, calls and decks from 2018, newest first.
U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®
December 17, 2018
Crescita Therapeutics(TM) Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive Adjusted EBITDA of $0.8M
November 9, 2018
Crescita Reinvigorates Skincare Line Leveraging its MMPE(TM) Technology and Becomes One of the First Companies Worldwide to Release Anti-Ageing Formulation Using ECOBIOTYS®
November 8, 2018
Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol
October 15, 2018
Crescita Therapeutics(TM) Reports 2018 Second Quarter Results
August 10, 2018
Crescita Therapeutics Inc. to Present at The MicroCap Conference on June 21st in Toronto
June 19, 2018
Crescita Therapeutics(TM) Announces Director Election Results of its Annual General Meeting
June 13, 2018
Crescita Therapeutics(TM) Reports 2018 First Quarter Results
May 9, 2018
Crescita Therapeutics(TM) To Present at the 2018 Bloom Burton &Co. Healthcare Investor Conference in Toronto
April 26, 2018
Crescita Therapeutics Inc. Adds Recognized Skincare Expert to its Leadership Team
April 5, 2018
Crescita Therapeutics(TM) Announces the Appointment of Serge Verreault as President & CEO
April 3, 2018
Crescita Announces Launch of Pliaglis in U.S.
March 29, 2018
Crescita Therapeutics(TM) Reports 2017 Fourth Quarter and Year End Results
March 28, 2018
Crescita Therapeutics Inc. Announces Completion of Oversubscribed Rights Offering
March 12, 2018
Crescita Therapeutics Inc. Announces Rights Offering to Raise Up To $3.7 Million
January 31, 2018